Article Text
Therapeutics
Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo
Statistics from Altmetric.com
OpenUrlCrossRefPubMedWeb of Science
Q Is once-daily atomoxetine more effective than placebo at reducing attention deficit hyperactivity disorder (ADHD) symptoms displayed at school?
METHODS
Design:
Multicentre randomised controlled trial.
Allocation:
Concealed.
Blinding:
Double blind.
Follow up period:
Seven weeks.
Setting:
Eight sites in the USA, two in Canada, and one in Puerto Rico.
Patients:
153 children aged 8–12 years with ADHD (DSM-IV); with symptom severity on the investigator administered ADHD Rating Scale-IV-Teacher Version (ADHDRS-IV-Teacher:Inv) at least 1.0 standard deviation (SD) above age and gender norms, and at least 1.5 SD above norms on …
Footnotes
For correspondence: Dr A J Allen, Lilly Corporate Center, Indianapolis, IN 46285, USA; allenaj{at}lilly.com
Sources of funding: Eli Lilly and Company.